CLINICAL_TRIALS
trial_result
· 2020-07-07
Clinical Trial Update: OsteoCool Tumor Ablation Post-Market Study [NA]
Summary
Post-market study for OsteoCool tumor ablation completed; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: MedtronicNeuro | Conditions: Metastasis Spine, Metastasis to Bone | NA | Status: COMPLETED | Results posted: 2020-07-07